Buzz

Join The Family Get The Latest News and Thoughts from ICONYC

Trialjectory
17
December
Buzz |

Trialjectory Uses Self-Reported Clinical Data to Match Cancer Patients With Clinical Trials / Techcrunch

December 17, 2019 by Roni Livneh

Trialjectory, which is developing a new technology service to match cancer patients with clinical trials, has raised $2.7 million to finance its continued growth.

Led by Contour Venture Partners,  the new financing will be used to accelerate Trialjectory’s operations by adding more clinical trials for different cancer types and expanding the company’s outreach to caregivers, pharmaceutical companies and patients, the company said.

“As cancer is the second leading cause of death for Americans — with thousands of new cases diagnosed each year — having access to advanced treatment options is a necessity, not a privilege, as new trials provide better outcomes to patients,” said Tzvia Bader, Trialjectory chief executive and co-founder. “What’s more, one of the top obstacles that oncologists face today is the lack of clinical trial access for patients, which is due to the availability of more treatment options overall. Additionally, it is a very complex process to match the right patient with the right treatment, especially with the rise of personalized medicine.”

The company currently supports trials for breast cancer, colon cancer, bladder cancer, melanoma and myelodysplastic syndromes. Read more. 

More in

Buzz |

Can these guys find the next Waze? / CNN Money

May 5, 2015 by Eyal Bino
Buzz |

5 Lessons Entrepreneurs Can Learn from Israeli Tech Founders / Entrepreneur

July 22, 2016 by Eyal Bino
Buzz |

Academic Plagiarism Detection Startup Raises $1.1 Million / Calcalist

April 1, 2018 by Rae Keinan
Buzz |

MyndYou and Genesis Rehab Services Awarded $900,000 Grant / Cision

April 25, 2018 by Rae Keinan